St. Louis, Missouri – Bayer AG has proposed a nationwide settlement of $7.25 billion to resolve thousands of lawsuits related to its herbicide Roundup, which contains glyphosate. This settlement comes as the company faces claims from approximately 65,000 individuals in both state and federal courts who allege that exposure to the product has led to their diagnosis of non-Hodgkin lymphoma and other cancers.
The settlement, announced Tuesday, proposes that Bayer will contribute to an established fund over a period of up to 21 years. The payout for each claimant will depend on various factors, including the duration of Roundup usage, the individual’s age at diagnosis, and the severity of their condition. Notably, the agreement does not require Bayer to admit any liability or wrongdoing.
Bayer has consistently maintained that its research supports the safety of glyphosate when used as directed. The company argues that decades of scientific assessments demonstrate the herbicide’s safety for consumers. However, this lawsuit settlement has been motivated by ongoing litigation uncertainties that have lingered for years.
For Bayer, this settlement represents a strategic move to close a chapter on extensive litigation that began with its acquisition of Monsanto in 2018 for $63 billion. Despite previously spending around $10 billion to settle earlier cases, the company has struggled to resolve claims related to potential future lawsuits stemming from Roundup use.
A critical component of the proposed settlement is that a minimum number of plaintiffs must opt into the agreement for it to be valid. If an excessive number choose to opt out, Bayer reserves the right to withdraw the offer. The settlement awaits approval from the St. Louis Circuit Court, where the case was initially filed.
Bayer’s legal challenges are further complicated by a pending U.S. Supreme Court case that could limit the company’s liability regarding Roundup. The Court’s decision will address whether federal regulations concerning pesticide endorsement preempt state laws governing product labeling and warnings. Currently, the Environmental Protection Agency approves Roundup’s label, which does not include a cancer warning, but individual states still maintain the authority to enforce their own public safety laws.
As Bayer prepares its case for the Supreme Court, the outcomes could potentially alter the landscape for future claims and existing verdicts against the company. A ruling siding with Bayer could nullify several significant verdicts that are under appeal. Additionally, it could impact those who choose not to participate in the current settlement, shielding the company from further lawsuits based on state labeling requirements.
Overall, the proposed settlement is poised to redefine Bayer’s ongoing legal strategies and provide a pathway to resolution for thousands of affected individuals navigating the aftermath of their cancer diagnoses linked to Roundup use.